Author Archives: Tom Halkin
When The Cancer Genome Atlas (TCGA) launched in 2006, it was a huge moment for cancer research. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) had come together to deliver researchers a better understanding of the molecular basis of cancer through the application of genome analysis and sequencing technologies.
California brain tumor patients scored a win in early October when Governor Jerry Brown signed a bill into law that will make oral chemotherapy more affordable and accessible. California Assembly Bill AB 219, authored by Assembly Member Henry Perea (D-Fresno), would limit the out of pocket expense for orally administered anti-cancer medications to $200 per 30-day supply […]
National Brain Tumor Society launched our Defeat GBM Research Collaborative in March of 2013 to great enthusiasm from both the patient and scientific communities. As our boldest strategic research initiative to-date, the Defeat GBM Research Collaborative aims to double the five-year survival rate of glioblastoma multiforme (GBM) patients in just five years.